Related Experiment Video
Updated: Jan 15, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Pan-Immune-Inflammatory value and risk of latent tuberculosis infection
Xiaoyan Ye1,2, Xia Kang3, Hui Zhang4
1Department of Infection Control, West China Hospital, Sichuan University, No. 37, Guoxue Alley, Wuhou District, Chengdu, Sichuan Province, China. xiaoyanyesci@163.com.
Abstract:
To investigate the association between the Pan-Immune-Inflammatory Value (PIV) and the risk of latent tuberculosis infection (LTBI) using a nationally representative sample from the United States. This study utilized data from 4877 adult participants in the National Health and Nutrition Examination Survey (NHANES) 2011-2012 cycle. PIV was calculated using neutrophil, monocyte, platelet, and lymphocyte counts. LTBI was assessed using the QuantiFERON-TB Gold In-Tube (QFT-GIT) test. Multivariable logistic regression was used to evaluate the association between PIV and LTBI risk. Subgroup analyses and Restricted Cubic Spline (RCS) analysis were performed. Cox regression analysis was used to examine the association of PIV with all-cause mortality among LTBI patients. Individuals with LTBI had significantly lower PIV levels compared to those without LTBI. Logistic regression analysis showed a significant negative correlation between PIV and LTBI risk, even after adjusting for covariates. The RCS analysis confirmed a dose-response relationship. The association remained significant across various demographic subgroups. Among LTBI patients, those in the highest PIV quartile had a significantly increased risk of all-cause mortality after full adjustment. PIV is negatively associated with the risk of LTBI. Additional extensive prospective investigations are required to validate these results.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Other Pulmonary Disorders

